OPKO Health Inc (OPK.N)

OPK.N on New York Stock Exchange

16.25USD
2 Jul 2015
Change (% chg)

$-0.02 (-0.12%)
Prev Close
$16.27
Open
$16.34
Day's High
$16.34
Day's Low
$16.01
Volume
790,895
Avg. Vol
894,042
52-wk High
$19.19
52-wk Low
$8.02

OPK.N

Chart for OPK.N

About

OPKO Health, Inc. (OPKO) is a biopharmaceutical and diagnostics company. The Company is involved in developing a range of solutions to diagnose, treat and prevent various conditions, including point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and pharmaceuticals and vaccines. It operates in two... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $7,449.40
Shares Outstanding(Mil.): 458.42
Dividend: --
Yield (%): --

Financials

  OPK.N Industry Sector
P/E (TTM): -- 35.83 39.81
EPS (TTM): -0.56 -- --
ROI: -18.71 17.03 16.23
ROE: -29.51 17.93 17.36
Search Stocks

Deals of the day- Mergers and acquisitions

June 4 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday:

04 Jun 2015

OPKO Health to buy Bio-Reference in $1.47 billion deal

- OPKO Health Inc agreed to buy clinical laboratory operator Bio-Reference Laboratories Inc in a stock deal valued at $1.47 billion to bolster its diagnostics business.

04 Jun 2015

OPKO Health to buy Bio-Reference in $1.47 bln deal

June 4 - OPKO Health Inc agreed to buy clinical laboratory operator Bio-Reference Laboratories Inc in a stock deal valued at $1.47 billion to bolster its diagnostics business.

04 Jun 2015

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks